Literature DB >> 26778480

Clinical Implications of Hip Flexion in the Measurement of Spinal Bone Mineral Density.

Shota Ikegami1, Mikio Kamimura2, Shigeharu Uchiyama3, Yukio Nakamura3, Keijiro Mukaiyama4, Hiroyuki Kato3.   

Abstract

The aim of this study was to investigate if differences in leg positioning affect spinal bone mineral density (BMD) measurements and the detection of low bone mass. Subjects included 1039 Japanese patients, 878 women and 161 men (mean ages: 67 and 71 years, respectively). Spinal BMD (L1-4) was measured using dual-energy X-ray absorptiometry (DXA) with patients lying in 2 different positions: (1) supine on the scanning table with hips flexed and knees flexed over a 90° support pad (the standard position) and (2) simply supine (the supine position). Predictive indices were calculated for spinal DXA acquired with patients in the supine position. A BMD T-score of -2.5 or lower was set as the threshold for low bone mass. For the standard and the supine positions during scanning in women, BMDs were 0.911 and 0.915 g/cm(2), respectively; in men, they were 1.117  and 1.124 g/cm(2), respectively. The estimated systematic bias in BMD between the positions was 0.42% (95% confidence interval: 0.24, 0.59; p = 0.009). Random errors in the densitometry measurements for the standard and supine positions were 0.66% and 0.84%, respectively. There was no significant difference between the errors (p= 0.164). The likelihood ratios of a positive and negative test for the detection of low bone mass following supine DXA were 121.0 and 0.066, respectively, compared with results acquired using the standard position. In conclusion, DXA measurements acquired with patients in the supine position slightly overestimated BMD vs the standard position. However, the clinical equivalency between the positioning methods for DXA is preserved to the extent that low bone mass can be reliably detected in the supine position.
Copyright © 2016 International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone mineral density; dual-energy X-ray absorptiometry; lumbar spine; osteoporosis; supine position

Mesh:

Year:  2016        PMID: 26778480     DOI: 10.1016/j.jocd.2015.11.002

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  4 in total

1.  Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy.

Authors:  Mikio Kamimura; Akira Taguchi; Yukio Nakamura; Hidefumi Koiwai; Shota Ikegami; Shigeharu Uchiyama; Hiroyuki Kato
Journal:  Ther Clin Risk Manag       Date:  2018-04-03       Impact factor: 2.423

2.  Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis.

Authors:  Mikio Kamimura; Shota Ikegami; Keijiro Mukaiyama; Hidefumi Koiwai; Yukio Nakamura; Akira Taguchi; Hiroyuki Kato
Journal:  Osteoporos Sarcopenia       Date:  2019-06-28

3.  Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.

Authors:  M Kamimura; Y Nakamura; S Ikegami; S Uchiyama; H Kato; A Taguchi
Journal:  Osteoporos Int       Date:  2016-09-20       Impact factor: 4.507

4.  Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment.

Authors:  Yukio Nakamura; Takako Suzuki; Mikio Kamimura; Kohei Murakami; Shota Ikegami; Shigeharu Uchiyama; Hiroyuki Kato
Journal:  Bone Res       Date:  2017-10-10       Impact factor: 13.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.